These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 12505690

  • 1. Cannabinoid pharmacology: implications for additional cannabinoid receptor subtypes.
    Wiley JL, Martin BR.
    Chem Phys Lipids; 2002 Dec 31; 121(1-2):57-63. PubMed ID: 12505690
    [Abstract] [Full Text] [Related]

  • 2. Evidence for a new G protein-coupled cannabinoid receptor in mouse brain.
    Breivogel CS, Griffin G, Di Marzo V, Martin BR.
    Mol Pharmacol; 2001 Jul 31; 60(1):155-63. PubMed ID: 11408610
    [Abstract] [Full Text] [Related]

  • 3. Enhancement of anandamide formation in the limbic forebrain and reduction of endocannabinoid contents in the striatum of delta9-tetrahydrocannabinol-tolerant rats.
    Di Marzo V, Berrendero F, Bisogno T, González S, Cavaliere P, Romero J, Cebeira M, Ramos JA, Fernández-Ruiz JJ.
    J Neurochem; 2000 Apr 31; 74(4):1627-35. PubMed ID: 10737621
    [Abstract] [Full Text] [Related]

  • 4. Cannabinoid receptor and WIN-55,212-2-stimulated [35S]GTPgammaS binding and cannabinoid receptor mRNA levels in several brain structures of adult male rats chronically exposed to R-methanandamide.
    Romero J, Berrendero F, García-Gil L, Lin SY, Makriyannis A, Ramos JA, Fernández-Ruiz JJ.
    Neurochem Int; 1999 Jun 31; 34(6):473-82. PubMed ID: 10402222
    [Abstract] [Full Text] [Related]

  • 5. Dysregulation of the endogenous cannabinoid system in adult rats prenatally treated with the cannabinoid agonist WIN 55,212-2.
    Castelli MP, Paola Piras A, D'Agostino A, Pibiri F, Perra S, Gessa GL, Maccarrone M, Pistis M.
    Eur J Pharmacol; 2007 Nov 14; 573(1-3):11-9. PubMed ID: 17644084
    [Abstract] [Full Text] [Related]

  • 6. FAAH-/- mice display differential tolerance, dependence, and cannabinoid receptor adaptation after delta 9-tetrahydrocannabinol and anandamide administration.
    Falenski KW, Thorpe AJ, Schlosburg JE, Cravatt BF, Abdullah RA, Smith TH, Selley DE, Lichtman AH, Sim-Selley LJ.
    Neuropsychopharmacology; 2010 Jul 14; 35(8):1775-87. PubMed ID: 20357755
    [Abstract] [Full Text] [Related]

  • 7. Levels, metabolism, and pharmacological activity of anandamide in CB(1) cannabinoid receptor knockout mice: evidence for non-CB(1), non-CB(2) receptor-mediated actions of anandamide in mouse brain.
    Di Marzo V, Breivogel CS, Tao Q, Bridgen DT, Razdan RK, Zimmer AM, Zimmer A, Martin BR.
    J Neurochem; 2000 Dec 14; 75(6):2434-44. PubMed ID: 11080195
    [Abstract] [Full Text] [Related]

  • 8. Cannabinoid receptor and WIN-55,212-2-stimulated [35S]GTP gamma S binding and cannabinoid receptor mRNA levels in the basal ganglia and the cerebellum of adult male rats chronically exposed to delta 9-tetrahydrocannabinol.
    Romero J, Berrendero F, García-Gil L, Ramos JA, Fernández-Ruiz JJ.
    J Mol Neurosci; 1998 Oct 14; 11(2):109-19. PubMed ID: 10096037
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of cannabimimetic effects of structural analogs of anandamide in rats.
    Wiley JL, Ryan WJ, Razdan RK, Martin BR.
    Eur J Pharmacol; 1998 Aug 21; 355(2-3):113-8. PubMed ID: 9760024
    [Abstract] [Full Text] [Related]

  • 10. Loss of cannabinoid-stimulated guanosine 5'-O-(3-[(35)S]Thiotriphosphate) binding without receptor down-regulation in brain regions of anandamide-tolerant rats.
    Rubino T, Viganò D, Costa B, Colleoni M, Parolaro D.
    J Neurochem; 2000 Dec 21; 75(6):2478-84. PubMed ID: 11080200
    [Abstract] [Full Text] [Related]

  • 11. Effects of chronic treatment with delta9-tetrahydrocannabinol on cannabinoid-stimulated [35S]GTPgammaS autoradiography in rat brain.
    Sim LJ, Hampson RE, Deadwyler SA, Childers SR.
    J Neurosci; 1996 Dec 15; 16(24):8057-66. PubMed ID: 8987831
    [Abstract] [Full Text] [Related]

  • 12. Assessment of anandamide interaction with the cannabinoid brain receptor: SR 141716A antagonism studies in mice and autoradiographic analysis of receptor binding in rat brain.
    Adams IB, Compton DR, Martin BR.
    J Pharmacol Exp Ther; 1998 Mar 15; 284(3):1209-17. PubMed ID: 9495885
    [Abstract] [Full Text] [Related]

  • 13. Inhibitory effects of cannabinoid receptor ligands on electrically-evoked responses in rat isolated tracheal ring segments.
    Yousif MH, Oriowo MA.
    Pharmacol Res; 1999 Nov 15; 40(5):415-21. PubMed ID: 10527656
    [Abstract] [Full Text] [Related]

  • 14. Cannabinoid CB(1) receptor expression, activation and detection of endogenous ligand in trabecular meshwork and ciliary process tissues.
    Stamer WD, Golightly SF, Hosohata Y, Ryan EP, Porter AC, Varga E, Noecker RJ, Felder CC, Yamamura HI.
    Eur J Pharmacol; 2001 Nov 23; 431(3):277-86. PubMed ID: 11730719
    [Abstract] [Full Text] [Related]

  • 15. Novel, not adenylyl cyclase-coupled cannabinoid binding site in cerebellum of mice.
    Monory K, Tzavara ET, Lexime J, Ledent C, Parmentier M, Borsodi A, Hanoune J.
    Biochem Biophys Res Commun; 2002 Mar 22; 292(1):231-5. PubMed ID: 11890697
    [Abstract] [Full Text] [Related]

  • 16. Highly selective CB(1) cannabinoid receptor ligands and novel CB(1)/VR(1) vanilloid receptor "hybrid" ligands.
    Di Marzo V, Bisogno T, De Petrocellis L, Brandi I, Jefferson RG, Winckler RL, Davis JB, Dasse O, Mahadevan A, Razdan RK, Martin BR.
    Biochem Biophys Res Commun; 2001 Feb 23; 281(2):444-51. PubMed ID: 11181068
    [Abstract] [Full Text] [Related]

  • 17. Activation of brain-type cannabinoid receptors interferes with preimplantation mouse embryo development.
    Yang ZM, Paria BC, Dey SK.
    Biol Reprod; 1996 Oct 23; 55(4):756-61. PubMed ID: 8879486
    [Abstract] [Full Text] [Related]

  • 18. AM630, a competitive cannabinoid receptor antagonist.
    Pertwee R, Griffin G, Fernando S, Li X, Hill A, Makriyannis A.
    Life Sci; 1995 Oct 23; 56(23-24):1949-55. PubMed ID: 7776818
    [Abstract] [Full Text] [Related]

  • 19. Receptor-independent effects of natural cannabinoids in rat peritoneal mast cells in vitro.
    Bueb JL, Lambert DM, Tschirhart EJ.
    Biochim Biophys Acta; 2001 Apr 23; 1538(2-3):252-9. PubMed ID: 11336796
    [Abstract] [Full Text] [Related]

  • 20. Endocannabinoid 2-arachidonyl glycerol is a full agonist through human type 2 cannabinoid receptor: antagonism by anandamide.
    Gonsiorek W, Lunn C, Fan X, Narula S, Lundell D, Hipkin RW.
    Mol Pharmacol; 2000 May 23; 57(5):1045-50. PubMed ID: 10779390
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.